Adverse events322

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 322

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	18	159	26
other	Anaemia	Blood and lymphatic system disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Hypothyroidism	Endocrine disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	14	159	16
other	Hypothyroidism	Endocrine disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Abdominal pain	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	13	159	14
other	Abdominal pain	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Constipation	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	40	159	47
other	Constipation	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Diarrhoea	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	31	159	38
other	Diarrhoea	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	1	3	1
other	Nausea	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	23	159	29
other	Nausea	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Vomiting	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	16	159	22
other	Vomiting	Gastrointestinal disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Asthenia	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	35	159	44
other	Asthenia	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	1	3	1
other	Chest pain	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	8	159	8
other	Chest pain	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0
other	Fatigue	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC First Course	35	159	39
other	Fatigue	General disorders	Recurrent or Metastatic Cutaneous and Locally Advanced Unresectable cSCC Second Course	0	3	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03284424/events

API reference For AI assistants

Adverse events322

Sources 3

Read this list from software.